scispace - formally typeset
Open AccessJournal ArticleDOI

Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities

TLDR
Recent progress in the chemistry and biology of these diverse microtubule stabilizers focusing on the wide range of organisms that produce these compounds, their mechanisms of inhibiting microtubules-dependent processes, mechanisms of drug resistance, and their interactions with tubulin including their distinct binding sites and modes are covered.
About
This article is published in Natural Product Reports.The article was published on 2014-02-11 and is currently open access. It has received 113 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Pyridine Moiety: Recent Advances in Cancer Treatment

TL;DR: This review throws light on recent biological expansions of pyridine along with their structure activity relationships/molecular docking to deliver association between various synthesized newer derivatives and receptor sites.
Journal ArticleDOI

Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3′,4′,5′-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold

TL;DR: The cell apoptosis study found that compounds 3a and 3b were very effective in the induction of apoptosis in a dose-dependent manner and did not induce cell death in normal human peripheral blood mononuclear cells, suggesting that they may be selective against cancer cells.
Journal ArticleDOI

Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids

TL;DR: Flow cytometry clearly showed that both CDCA and UDCA conjugation to PTX improved its incoming into HCT116 cells, allowing the derivatives to enter the cells up to 99.9%, respect to 35% in the case of PTX.
Journal ArticleDOI

3-Vinylazetidin-2-Ones: Synthesis, antiproliferative and tubulin destabilizing activity in MCF-7 and MDA-MB-231 Breast Cancer Cells

TL;DR: A series of 3-vinyl-β-lactams (2-azetidinones) were designed, synthesized and evaluated as potential tubulin polymerization inhibitors, and for their antiproliferative effects in breast cancer cells.
Journal ArticleDOI

Indazole-based microtubule-targeting agents as potential candidates for anticancer drugs discovery.

TL;DR: In this article , the authors present the advances in research on compounds containing indazole scaffolds as microtubule targeting agents based on the articles published in the last two decades, and find that compounds 6 and 7 showed the lowest IC50 values of 0.6 ∼ 0.9 nM in the cell line studies.
References
More filters
Journal ArticleDOI

Microtubules as a target for anticancer drugs.

TL;DR: Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy, and it is now known that at lower concentrations, microtubule-targeted drugs can suppress micro Tubule dynamics without changingmicrotubule mass; this action leads to mitotic block and apoptosis.
Journal ArticleDOI

Promotion of microtubule assembly in vitro by taxol

TL;DR: It is reported here that taxol acts as a promoter of calf brain microtubule assembly in vitro, in contrast to plant products such as colchicine and podophyllotoxin, which inhibit assembly.
Journal ArticleDOI

Microtubule-binding agents: a dynamic field of cancer therapeutics

TL;DR: The screening of a range of botanical species and marine organisms has yielded promising new antitubulin agents with novel properties, and the three main objectives are enhanced tumour specificity, reduced neurotoxicity and insensitivity to chemoresistance mechanisms.
Journal Article

Epothilones, a New Class of Microtubule-stabilizing Agents with a Taxol-like Mechanism of Action

TL;DR: Epothilones represent a novel structural class of compounds, the first to be described since the original discovery ofTaxol, which not only mimic the biological effects of taxol but also appear to bind to the same microtubule-binding site as taxol.
Related Papers (5)